Binge Eating Disorder: Should You Use Vyvanse?
The Carlat Psychiatry Report, Volume 13, Number 6, June 2015
https://www.thecarlatreport.com/newsletter-issue/tcprv13n6/
Issue Links: Learning Objectives | Editorial Information
Topics: Eating Disorders | Practice Tools and Tips | Psychopharmacology Tips | Psychotherapy
Talia Puzantian, PharmD, BCPP
Clinical psychopharmacology consultant in private practice, Los Angeles, CA. www.taliapuzantian.com
Dr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.
You can't view details of this content, please login or buy subscription here